Clinical-diffusion mismatch and benefit from thrombolysis 3 to 6 hours after acute stroke

Stroke

Volumn 40, Issue 7, 2009, Pages 2572-2574

  Ebinger, Martin ^a   Iwanaga, Takeshi ^f   Prosser, Jane F ^a   De Silva, Deidre A ^a   Christensen, Soren ^a   Collins, Marnie ^b   Parsons, Mark W ^c   Levi, Christopher R ^c   Bladin, Christopher F ^d   Barber, P Alan ^e   Donnan, Geoffrey A ^f   Davis, Stephen M ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d BOX HILL HOSPITAL   (Australia)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f AUSTIN HOSPITAL   (Australia)

Author keywords

clinical diffusion mismatch; MRI; Stroke; tPA

Indexed keywords

PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ARTICLE; BRAIN DAMAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CLINICAL DIFFUSION MISMATCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION DIFFUSION MISMATCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION; SENSITIVITY AND SPECIFICITY; STROKE;

DOUBLE-BLIND METHOD; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; SENSITIVITY AND SPECIFICITY; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 67650094822     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.548073     Document Type: Article

References (5)

1. Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J. The clinical-DWI mismatch: A new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004;62: 2187-2192.
2. Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S. Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke. 2005;36:1700-1704.
3. Lansberg MG, Thijs VN, Hamilton S, Schlaug G, Bammer R, Kemp S, Albers GW. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in defuse. Stroke. 2007;38:1826-1830.
4. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): A placebo-controlled randomised trial. Lancet Neurol. 2008;7:299 -309.
5. Tei H, Uchiyama S, Usui T. Clinical-diffusion mismatch defined by NIHSS and aspects in non-lacunar anterior circulation infarction. J Neurol. 2007;254:340-346.